COO
COOPER CO (COO)
NASDAQ
$61.52-$0.13 (-0.22%)
Price as of Oct 23, 2026 7:32 AM EDT
  • $11.7B
    Market Cap
  • -17.27%
    1-Year Change
  • Medical Instruments & Supplies
    Industry

Key Performance

More
  • Earnings Score: 55
  • Momentum Score: 17
  • True Yield: N/A
  • Financial Health Score: 64
TradeSmith Loading

Latest Research & News

The Cooper Companies, Inc. Investor News: If You Have Suffered Losses in The Cooper Companies, Inc., You Are Encouraged to Contact The Rosen Law Firm About Your Rights

The Rosen Law Firm is investigating potential securities claims against The Cooper Companies, Inc. following a 14.6% stock decline on September 10, 2026, after disappointing earnings guidance and a decision not to sell Cooper Surgical. Investors who purchased Cooper Companies securities may be eligible for compensation through a class action lawsuit.

10/22/2026, 6:29 PM • GlobeNewswire

The Cooper Companies, Inc. Investor News: If You Have Suffered Losses in The Cooper Companies, Inc., You Are Encouraged to Contact The Rosen Law Firm About Your Rights

Rosen Law Firm is investigating potential securities claims against The Cooper Companies, Inc. (NASDAQ: COO) for allegedly issuing materially misleading business information. The investigation was prompted by Cooper Companies' disappointing earnings report on September 10, 2026, which included weak guidance and a decision not to sell Cooper Surgical, causing the stock to fall 14.6% that day. Investors who purchased Cooper Companies securities may be eligible for compensation through a class action lawsuit.

10/19/2026, 8:23 PM • GlobeNewswire

The Cooper Companies, Inc. Investor News: If You Have Suffered Losses in The Cooper Companies, Inc., You Are Encouraged to Contact The Rosen Law Firm About Your Rights

Rosen Law Firm has launched an investigation into potential securities claims against The Cooper Companies, Inc. (NASDAQ: COO) following allegations of materially misleading business information. The investigation was prompted by Cooper Companies' September 10, 2026 earnings report that disappointed Wall Street with weak guidance and a decision not to sell Cooper Surgical, resulting in a 14.6% stock decline. The firm is preparing a class action lawsuit to recover investor losses on a contingency fee basis.

10/16/2026, 2:56 PM • GlobeNewswire

Sprout Social Investor News: If You Own Stock in Sprout Social, Inc., You Are Encouraged to Contact The Rosen Law Firm About Your Rights

Rosen Law Firm has announced an investigation into potential breaches of fiduciary duties by directors and officers of Sprout Social, Inc. The firm is encouraging current shareholders to contact them regarding their rights. Rosen Law Firm is also investigating securities claims for The Cooper Companies, Inc. and has filed a class action lawsuit for Netcapital Inc. investors.

10/16/2026, 2:54 PM • GlobeNewswire

Recently Appointed Cooper Companies Director Paul Keel Buys $250,000 Stock. Does This Signal Shares are a Buy?

Cooper Companies director Paul Keel purchased 4,701 shares worth $250,000 at $53.18 per share on September 11, 2026, following a 21% year-long stock decline. The insider buy is viewed as a bullish signal, suggesting confidence in the company's long-term growth prospects. Keel, who recently joined Cooper's board in May, brings extensive experience from his CEO role at Envista Holdings and prior positions at 3M.

10/07/2026, 10:38 AM • The Motley Fool

The Cooper Companies, Inc. Investor News: If You Have Suffered Losses in The Cooper Companies, Inc., You Are Encouraged to Contact The Rosen Law Firm About Your Rights

Rosen Law Firm is investigating potential securities claims against The Cooper Companies, Inc. (NASDAQ: COO) for allegedly issuing materially misleading business information. The investigation was prompted by Cooper Companies' September 10, 2026 earnings report that disappointed Wall Street with weak guidance and a decision not to sell Cooper Surgical, causing the stock to fall 14.6% that day. Investors who purchased Cooper Companies securities may be eligible for compensation through a class action lawsuit.

10/06/2026, 1:59 PM • GlobeNewswire

Securities Fraud Investigation Into The Cooper Companies, Inc. (COO) Continues – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm

The Cooper Companies faces a securities fraud investigation following disappointing Q3 2026 results. The company reported flat year-over-year revenue of $717 million, attributed to U.S. channel inventory reductions. Cooper lowered full-year guidance by approximately 1.4% in revenue and 1.8% in EPS, causing shares to decline 14.67% on September 10, 2026.

10/05/2026, 11:00 AM • GlobeNewswire

Cooper Companies Director Kurzius Buys $549,300 in Shares. Is the Eye Care Stock About to Rally?

Lawrence Erik Kurzius, a Director at Cooper Companies, purchased 10,000 shares worth $549,300 at $54.93 per share on September 16, 2026, increasing his total holdings to 31,099 shares. The insider buy signals confidence in the company's recovery prospects following a 16% stock decline over the past year. The article notes that insider purchases typically predict higher share prices within 30 days and suggest management believes in the company's long-term growth, particularly after deciding to retain its surgical unit rather than divest it.

10/02/2026, 1:11 PM • The Motley Fool

The Cooper Companies, Inc. Investor News: If You Have Suffered Losses in The Cooper Companies, Inc., You Are Encouraged to Contact The Rosen Law Firm About Your Rights

Rosen Law Firm has announced an investigation into potential securities claims against The Cooper Companies, Inc. (NASDAQ: COO) for allegedly issuing materially misleading business information. The investigation was triggered by CooperCompanies' disappointing earnings report on September 10, 2026, which included weak guidance and a decision not to sell CooperSurgical, causing the stock to fall 14.6%. Investors who purchased CooperCompanies securities may be eligible for compensation through a class action lawsuit.

09/25/2026, 9:05 PM • GlobeNewswire

COOPER COMPANIES, INC. INVESTIGATION: COO Securities Investors Encouraged to Contact Kirby McInerney LLP About Their Rights

Law firm Kirby McInerney LLP is investigating potential securities law violations by Cooper Companies following the company's September 9, 2026 earnings announcement. CooperCompanies reported Q3 revenue of $1.07 billion, missing analyst expectations of $1.10 billion, with its CooperVision segment showing flat year-over-year growth. The company attributed underperformance to proactive U.S. channel inventory reductions. The stock declined 14.7% on the news, falling from $63.48 to $54.17 per share.

09/15/2026, 3:33 PM • GlobeNewswire

The Cooper Companies (NASDAQ: COO) Scrutinized Over U.S. Channel Inventory Reductions Driving Stock Sharply Lower -- HBSS

The Cooper Companies' stock plummeted 14.6% on September 10, 2026, after Q3 2026 earnings revealed significant U.S. channel inventory destocking at its CooperVision segment. The company reduced full-year revenue guidance to flat or down 2% organically, attributing the decline entirely to inventory reductions. Hagens Berman has opened an investigation into whether Cooper was sufficiently transparent about its sales practices and potential securities law violations.

09/12/2026, 2:49 PM • GlobeNewswire

3 Undervalued Stocks to Buy in a Rotating Market

As the stock market rotates away from mega-cap tech, three undervalued stocks offer compelling opportunities: Keurig Dr Pepper trades at a discount to beverage peers with attractive dividend yield; Cooper Companies benefits from healthcare sector resilience with strong EPS growth prospects; and Matador Resources capitalizes on the energy sector's 21% YTD surge with robust revenue growth and cash flow metrics.

02/18/2026, 12:24 PM • Investing

3 Undervalued Stocks to Buy in a Rotating Market

As the stock market rotates away from mega-cap tech, three undervalued stocks offer compelling opportunities: Keurig Dr Pepper trades at a discount to beverage peers with attractive dividend yields; Cooper Companies benefits from healthcare sector resilience with strong EPS growth prospects; and Matador Resources capitalizes on the energy sector's 21% YTD surge with robust revenue growth and cash flow generation.

02/18/2026, 11:08 AM • Investing

3 Undervalued Stocks to Buy in a Rotating Market

As market leadership shifts and investors rotate away from mega-cap growth stocks, three undervalued companies offer compelling opportunities: Keurig Dr Pepper trades at a discount to beverage peers with attractive dividend yields; Cooper Companies benefits from healthcare sector resilience with strong EPS growth prospects; and Matador Resources capitalizes on the energy sector's 21% YTD surge with robust revenue growth and cash flow generation.

02/18/2026, 7:38 AM • Investing

3 Undervalued Stocks to Buy in a Rotating Market

As the stock market rotates away from mega-cap growth stocks, three undervalued companies offer compelling opportunities: Keurig Dr Pepper trades at a discount to beverage peers with attractive dividend yields; Cooper Companies benefits from healthcare sector resilience with strong EPS growth prospects; and Matador Resources capitalizes on the energy sector's 21% YTD surge with robust revenue growth and cash flow generation.

02/18/2026, 6:44 AM • Investing

Peers

Statistics

More
Day Range
$59.27
$61.66
$61.65
1-Year Range
$53.27
$84.32
$61.65
Latest Close$61.65
Change
+$2.68 (+4.35%)
Volume3,510,217
Market Cap$11.7B
Shares Outstanding190.2M
P/E (TTM)21.17
Diluted EPS (TTM)$2.91
Enterprise Value$14.1B

Information as of 10/22/2026

Company Profile

COOPER COMPANIES INC
COOPER COMPANIES INC
https://www.coopercos.com
$11.7B
Market Cap
$570.3M
Net Income
Sector: Healthcare
Industry: Medical Instruments & Supplies
6101 Bollinger Canyon Road, San Ramon, CA, United States, 94583
925 460 3600

The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical, toric, and multifocal contact lenses that address vision challenges, such as astigmatism, presbyopia, and myopia. Its CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage. This segment offers Paragard, a hormone-free intrauterine device; and fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing. The company sells its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.

Key Executives

  • Albert G. White
  • Daniel G. McBride
  • Brian G. Andrews
  • Holly R. Sheffield
  • Gerard H. Warner

Current Ownership Distribution

  • Institutions2.3B (54.21%)
  • Mutual Funds1.9B (45.75%)
  • Insiders1.8M (0.04%)
  • Other0 (0.00%)